States in Medical Technology
Navigation Links
States in Medical Technology
... Enforcement Investigations Center, United states Environmental Protection Agency; and Harvey Pass, ... at Karmanos)
In response to the United states Environmental Protection Agency's (EPA) ... comprehensive cancer centers in the United states . Caring for nearly 6,000 new patients annually ...
... form of modafinil, was launched in the United states in June 2009 and is indicated to improve ... employs approximately 3,000 people in the United states and Europe. U.S. sites include the company's ... The company's proprietary products in the United states include: NUVIGIL, TREANDA(R) (bendamustine ...
... approximately 1.3 million people in the United states and more than three million people in Europe. ... SIMPONI is approved in Canada and the United states and is available either through the SIMPONI ... exclusive marketing rights outside the United states except in Japan, Indonesia and Taiwan, where ...
... commonly used by millions of adults in the United states who suffer from acid reflux. ADHD is estimated ... section of the ADDERALL XR product labeling states that coadministration of ADDERALL XR and proton ... VYVANSE, which was introduced in the United states in July 2007 for the treatment of ADHD in ...
... approximately 5.3 million people in the United states alone(ii). Every 70 seconds, an American is ... see Lilly's filing with the United states Securities and Exchange Commission. Lilly ... statements. i. USAN (United states Adoptive Name council) adopted, INN ...
... approximately 200,000 people in the United states and Europe combined, with approximately 30,000 new cases reported per year in each of the United states and Europe. IPF is characterized by ... the regulatory authorities in either the United states or Europe will grant regulatory approval based ...
... new intravenous analgesic approved in the United states in more than 20 years and the only approved ... for the treatment of pain and fever in the United states and is available in more than 600 combination and ... the exclusive rights to Acetavance in the United states and Canada in 2006 from Bristol-Myers Squibb ...
... (NDA) is planned for submission to the United states Food and Drug Administration (FDA) this year. The ... and has facilities throughout Europe, the United states and Asia. J&JPRD is leveraging drug discovery ... is a major health care company in the United states dedicated to the needs of primary care providers ...
... The dial-in number within the United states is 866-788-0540. The dial-in number for ... 2009. The dial-in number from within the United states is 888-286-8010. For international callers, the ... formed to meet the critical needs of the United states and its allies by developing and commercializing ...
... combination therapy approved in the United states that is not restricted to treatment-naive ... that more than 100,000 patients in the United states failed prior treatment of their hepatitis C virus ... affecting nearly 5 million people in the United states alone. It is the leading cause of cirrhosis and ...
... a class action lawsuit was filed in the United states District Court for the Northern District of ... to the Company's Form 8-K filed with the United states Securities and Exchange Commission filed that ... and individual investors from the United states and around the world. For more information ...
... -- Hospital associations in 10 states have been selected to participate in a program to ... for Healthcare Research and Quality. The states are California, Colorado, Florida, Massachusetts, ... unit-based patient safety program across the 10 states to help prevent infections related to the use of ...
... other organs. Roughly 90,000 people in the United states are living with CLL, according to the Leukemia ... first monoclonal antibody approved by the United states Food and Drug Administration (FDA) for the ... Inc., as Campath, and outside the United states as MabCampath(R). For more information ...
... Campath is indicated in the United states as a single agent for the treatment of B-cell ... first monoclonal antibody approved by the United states Food and Drug Administration (FDA) for the ... Inc., as Campath, and outside the United states as MabCampath(R). For more information ...
... are currently over 160,000 women in the United states living with advanced breast cancer who are ... survival. Over 200,000 women in the United states are diagnosed with breast cancer each year and ... deaths per year due to the disease in the Unites states alone. Bionovo, Inc. Bionovo is a ...
... -- While 78 percent of mothers in the United states consider influenza a severe and potentially ... "We surveyed mothers throughout the United states to assess their awareness about a family's need ... was conducted via telephone within the United states by CARAVAN Opinion Research Corporation, on ...
... in Phase I trials in adults both in the United states and Spain. Millennium plans to expand the MLN8237 ... Aurora A kinase inhibitor, in the United states -- Lead investigator: Jeffrey R. Infante, ... Phase I trials in adults both in the United states and Japan. New TAK-285 non-clinical data ...
... the standard of hemophilia care in the United states so that it is now on par with other ... Science Center, and Director of the Mountain states Regional Hemophilia & Thrombosis Center at the ... one in 5,000 males born in the United states has hemophilia. About Bayer HealthCare LLC ...
... Status As previously announced, in the United states the Company continues to work with the COG as ... was granted orphan drug status in the United states in 2001. The NDA was submitted to FDA in October ... than 1,000 new cases diagnosed in the United states each year. A similar incidence of the disease ...
... Centers for Disease Control and Prevention (CDC) states that getting an annual flu vaccine is the single ... and about 36,000 deaths in the United states each year.(3) New Campaign Launches to Educate ... surveys were conducted online within the United states by Harris Interactive on behalf of MedImmune ...
... Society, an estimated 66,000 people in the United states will be diagnosed in 2008 with NHL. There ... injection, a product approved in the United states for the treatment of patients with relapsed or ... employs approximately 3,000 people in the United states and Europe. U.S. sites include the company's ...
... Status As previously announced, in the United states the Company continues to work with the COG as ... was granted orphan drug status in the United states in 2001. The NDA was submitted to FDA in October ... than 1,000 new cases diagnosed in the United states each year. A similar incidence of the disease ...
... FDA-approved HIFU clinical trials in the United states and abundant clinical data on HIFU outcomes and ... have the ability to travel outside of the United states to receive HIFU, a non invasive, outpatient ... FDA-approved clinical trials in the United states to gather data important for analysis of the ...
... is estimated that 27 million adults in the United states have osteoarthritis and the prevalence increases ... system. Cymbalta is approved in the United states for the acute and maintenance treatment of major ... see Lilly's filings with the United states Securities and Exchange Commission. Lilly ...
... THAT TERM IS DEFINED IN SECTION 27A OF THE UNITED states SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED states SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. ... REPORTS FILED FROM TIME TO TIME WITH THE UNITED states SECURITIES AND EXCHANGE COMMISSION, INCLUDING THE ...
... a supplemental new drug application in the United states later this year to expand the current product ... years of market exclusivity in the United states for relapsed/refractory pediatric ALL. The FDA ... honor awarded by the President of the United states for technological innovation. With many ...
... THAT TERM IS DEFINED IN SECTION 27A OF THE UNITED states SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED states SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. ... REPORTS FILED FROM TIME-TO-TIME WITH THE UNITED states SECURITIES AND EXCHANGE COMMISSION, INCLUDING THE ...
... form of modafinil, was launched in the United states in June 2009 and is indicated to improve ... employs approximately 3,000 people in the United states and Europe. U.S. sites include the company's ... The company's proprietary products in the United states include: NUVIGIL, TREANDA(R) (bendamustine ...
Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)
... Eighteen clinical sites throughout the United states are participating in the study. About ... has been granted orphan drug status in the United states by the FDA, and has received an orphan drug ... the leading organization in the United states devoted to curing and controlling cystic ...HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens
... compliance Mayberry points out. "In the United states today, the only class of drugs currently ... many benefits of unit dose packaging. The United states is one of only a few countries in the world where ... effort to the Obama administration and the United states Congress urging public policy that will bring ....Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
... The therapeutic portfolio in the United states includes two marketed products: TREANDA(R) ... for Injection, which is approved in the United states for the treatment of chronic lymphocytic leukemia ... employs approximately 3,000 people in the United states and Europe. U.S. sites include the company's ...... approximately 1.3 million people in the United states and more than three million people in Europe. ... SIMPONI is approved in Canada and the United states and is available either through the SIMPONI ... exclusive marketing rights outside the United states except in Japan, Indonesia and Taiwan, where ...
FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
... (Nasdaq: UTHR ) announced today that the United states Food and Drug Administration (FDA) has approved ... as we prepare to launch ADCIRCA in the United states at the beginning of August this year," said Roger ... ADCIRCA for pulmonary hypertension in the United states and Puerto Rico from Eli Lilly & Company in ...... commonly used by millions of adults in the United states who suffer from acid reflux. ADHD is estimated ... section of the ADDERALL XR product labeling states that coadministration of ADDERALL XR and proton ... VYVANSE, which was introduced in the United states in July 2007 for the treatment of ADHD in ...
... approximately 5.3 million people in the United states alone(ii). Every 70 seconds, an American is ... see Lilly's filing with the United states Securities and Exchange Commission. Lilly ... statements. i. USAN (United states Adoptive Name council) adopted, INN ...
... approximately 200,000 people in the United states and Europe combined, with approximately 30,000 new cases reported per year in each of the United states and Europe. IPF is characterized by ... the regulatory authorities in either the United states or Europe will grant regulatory approval based ...
... new intravenous analgesic approved in the United states in more than 20 years and the only approved ... for the treatment of pain and fever in the United states and is available in more than 600 combination and ... the exclusive rights to Acetavance in the United states and Canada in 2006 from Bristol-Myers Squibb ...
... (NDA) is planned for submission to the United states Food and Drug Administration (FDA) this year. The ... and has facilities throughout Europe, the United states and Asia. J&JPRD is leveraging drug discovery ... is a major health care company in the United states dedicated to the needs of primary care providers ...
... The dial-in number within the United states is 866-788-0540. The dial-in number for ... 2009. The dial-in number from within the United states is 888-286-8010. For international callers, the ... formed to meet the critical needs of the United states and its allies by developing and commercializing ...
Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
... in Phase I/II clinical trials in the United states and being developed for the treatment of solid ... Pan HDAC inhibitor product outside of the United states in rapid fashion," said Robert W. Duggan, ... inhibitor product worldwide except for the United states and will pay a royalty to Pharmacyclics on ...Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
... in the study traveled eastbound from the United states to France where they were then examined at a ... employs approximately 3,000 people in the United states and Europe. U.S. sites include the company's ... The company's proprietary products in the United states include: AMRIX(R) (cyclobenzaprine hydrochloride ...... combination therapy approved in the United states that is not restricted to treatment-naive ... that more than 100,000 patients in the United states failed prior treatment of their hepatitis C virus ... affecting nearly 5 million people in the United states alone. It is the leading cause of cirrhosis and ...
Research Finding Could Revolutionize Asthma Treatment
... of the National Academy of Sciences of the United states of America , a prestigious scientific journal. ... Nearly one in every 13 people in the United states has asthma -- more Americans than have coronary ... is the only national advocacy group in the United states devoted solely to asthma. According to Ms. ...... a class action lawsuit was filed in the United states District Court for the Northern District of ... to the Company's Form 8-K filed with the United states Securities and Exchange Commission filed that ... and individual investors from the United states and around the world. For more information ...
ACRO Comments on NEJM Article on Globalization of Clinical Research
... in this regard. Further, the article states "Investigators in developing countries would ... rate in clinical trials in the United states and Western Europe. According to the non-profit ... 80% of clinical trials in the United states are delayed at least one month because of ...... -- Hospital associations in 10 states have been selected to participate in a program to ... for Healthcare Research and Quality. The states are California, Colorado, Florida, Massachusetts, ... unit-based patient safety program across the 10 states to help prevent infections related to the use of ...
... other organs. Roughly 90,000 people in the United states are living with CLL, according to the Leukemia ... first monoclonal antibody approved by the United states Food and Drug Administration (FDA) for the ... Inc., as Campath, and outside the United states as MabCampath(R). For more information ...
... Campath is indicated in the United states as a single agent for the treatment of B-cell ... first monoclonal antibody approved by the United states Food and Drug Administration (FDA) for the ... Inc., as Campath, and outside the United states as MabCampath(R). For more information ...
Siemens Introduces New Standard of Care for Breast Ultrasound
... (1) 510 (k) pending; not available in the United states (2) Not available in the United states (3) N Engl J Med 356;3. Boyd N.F. et Al., ... Evaluations (5) Not available in the United states (6) Not available in the ...... are currently over 160,000 women in the United states living with advanced breast cancer who are ... survival. Over 200,000 women in the United states are diagnosed with breast cancer each year and ... deaths per year due to the disease in the Unites states alone. Bionovo, Inc. Bionovo is a ...
... -- While 78 percent of mothers in the United states consider influenza a severe and potentially ... "We surveyed mothers throughout the United states to assess their awareness about a family's need ... was conducted via telephone within the United states by CARAVAN Opinion Research Corporation, on ...
Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds
... reduction in the hip fracture rate in the United states if a more active role is taken by all orthopedic ... of the largest research programs in the United states and engage in work designed to improve the health ... Permanente serves 8.7 million members in nine states and the District of Columbia. Today it ...... in Phase I trials in adults both in the United states and Spain. Millennium plans to expand the MLN8237 ... Aurora A kinase inhibitor, in the United states -- Lead investigator: Jeffrey R. Infante, ... Phase I trials in adults both in the United states and Japan. New TAK-285 non-clinical data ...
... the standard of hemophilia care in the United states so that it is now on par with other ... Science Center, and Director of the Mountain states Regional Hemophilia & Thrombosis Center at the ... one in 5,000 males born in the United states has hemophilia. About Bayer HealthCare LLC ...
... Status As previously announced, in the United states the Company continues to work with the COG as ... was granted orphan drug status in the United states in 2001. The NDA was submitted to FDA in October ... than 1,000 new cases diagnosed in the United states each year. A similar incidence of the disease ...
... Centers for Disease Control and Prevention (CDC) states that getting an annual flu vaccine is the single ... and about 36,000 deaths in the United states each year.(3) New Campaign Launches to Educate ... surveys were conducted online within the United states by Harris Interactive on behalf of MedImmune ...
Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen
... The companies also announced that the United states Patent and Trademark Office granted the patent ... honor awarded by the President of the United states for technological innovation. With many ... line at 1-800-905-4369 within the United states or 1-678-999-4572 outside the United States. ...... Society, an estimated 66,000 people in the United states will be diagnosed in 2008 with NHL. There ... injection, a product approved in the United states for the treatment of patients with relapsed or ... employs approximately 3,000 people in the United states and Europe. U.S. sites include the company's ...
... Status As previously announced, in the United states the Company continues to work with the COG as ... was granted orphan drug status in the United states in 2001. The NDA was submitted to FDA in October ... than 1,000 new cases diagnosed in the United states each year. A similar incidence of the disease ...
... FDA-approved HIFU clinical trials in the United states and abundant clinical data on HIFU outcomes and ... have the ability to travel outside of the United states to receive HIFU, a non invasive, outpatient ... FDA-approved clinical trials in the United states to gather data important for analysis of the ...
Genzyme and Isis Complete Licensing of Mipomersen
... 15,000 apheresis-eligible patients in the United states and Europe. Genzyme and Isis expect to begin ... honor awarded by the President of the United states for technological innovation. With many ... line at 1-800-905-4369 within the United states or 1-678-999-4572 outside the United States. ...... is estimated that 27 million adults in the United states have osteoarthritis and the prevalence increases ... system. Cymbalta is approved in the United states for the acute and maintenance treatment of major ... see Lilly's filings with the United states Securities and Exchange Commission. Lilly ...
Anpath Group, Inc. Announces Addition of MRSA and VRE Claims for Its EnviroTru(R) Disinfectant
... believes should be completed with the majority of states within 30 days. EnviroTru(R) ( ... or so the number of MRSA infections in the United states has increased significantly. At the same time, a ... 18,650 hospital stay-related deaths in the United states in 2005. These figures suggest that MRSA ...... THAT TERM IS DEFINED IN SECTION 27A OF THE UNITED states SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED states SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. ... REPORTS FILED FROM TIME TO TIME WITH THE UNITED states SECURITIES AND EXCHANGE COMMISSION, INCLUDING THE ...
... a supplemental new drug application in the United states later this year to expand the current product ... years of market exclusivity in the United states for relapsed/refractory pediatric ALL. The FDA ... honor awarded by the President of the United states for technological innovation. With many ...
... THAT TERM IS DEFINED IN SECTION 27A OF THE UNITED states SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED states SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. ... REPORTS FILED FROM TIME-TO-TIME WITH THE UNITED states SECURITIES AND EXCHANGE COMMISSION, INCLUDING THE ...
Other ContentspolymyositisrheumaticapolydipsiapolyuriaporeporeporeporeporeporeporeOther TagsInjectInjectInjectInjectRapesRapesDalDalDalDalDalJuryJuryJury
(Date:12/14/2009)... -- (Dec. 14, 2009) -- Researchers at Rice University ... single nanoparticle that can be tracked in real time ... tags them with a fluorescent dye and kills them ... first examples from a growing field called "theranostics" that ... diseases in a single procedure. , The research is ...
(Date:12/14/2009)... the Biomedical Engineering Society (BMES) have founded a new ... ). CVET is a forum for ... treatment. The first issue of the new quarterly ... other BMES publications at Springer, Annals of Biomedical ... , Cardiovascular Engineering and Technology will present ...
(Date:12/14/2009)... tool use as a defining feature of humans. That,s until ... with birds and an array of other mammals. Now, a ... , a Cell Press publication, adds an octopus to the ... study manages a behavioral trick that the researchers call stilt ... upright coconut shell "bowls," makes its eight arms rigid, and ...
Breaking Biology News(10 mins):Tracking new cancer-killing particles with MRI 2Biomedical Engineering Society's new journal to be published by Springer 2Tool use in an invertebrate: The coconut-carrying octopus 2Phillies Star Rookie Pitcher J A Happ Wins MLB Players Choice Award 3B Designates Diabetes Research Institute as Charity of Choice 60192 1Phillies Star Rookie Pitcher J A Happ Wins MLB Players Choice Award 3B Designates Diabetes Research Institute as Charity of Choice 60192 2CDA Recommends Halloween Tips for Good Oral Health 60188 1CDA Recommends Halloween Tips for Good Oral Health 60188 2PDL BioPharma Reschedules Third Quarter 2009 Financial Results Conference Call for 8 3A30 a m ET on October 28 2009 14620 1PDL BioPharma Reschedules Third Quarter 2009 Financial Results Conference Call for 8 3A30 a m ET on October 28 2009 14620 2(Date:12/16/2009)... for your loved ones this holiday season, give them the gift ... running, child care, and pet care through Delegate Source. , ... ... the Denver and Boulder metro areas have the opportunity to give ... by using Delegate Source,s " Give a Gift " program to ...
(Date:12/15/2009)... Watchdog Calls For Preserving State Authority, Ban on ... ,, WASHINGTON, Dec. 15 Consumer Watchdog ... for those over 55 and the public option ... the group said that the Senate must still ... bill to prevent ceding the entire health care ...
(Date:12/15/2009)... lump of coal for lying about taxes in the healthcare ... Max Baucus has earned a place under the "Naughty" column ... List after being caught telling a brazen lie on ... Senate healthcare bill would not raise taxes. ,, Speaking ... ,, " I have also ...
(Date:12/15/2009)... of reproductive age were evaluated, Italian study found , , ... children born with cystic fibrosis decreases when screening for ... a new study finds. , CF neonatal screening has ... many years. Since the 1990s, the area has seen ... born with CF. , Two different CF carrier detection ...
(Date:12/15/2009)... Association and the CDC have released some sobering statistics concerning the ... Treadmill desks offer employers an effective means of combating this trend ... ... 14, 2009 -- Rates of diabetes are climbing across America due ... Despite this rise the American Diabetes Association has stated that the ...
Breaking Medicine News(10 mins):Health News:Give the Gift of Service This Holiday Season with Delegate Source 2Health News:Give the Gift of Service This Holiday Season with Delegate Source 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 4Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 5Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3[0] Give the Gift of Service This Holiday Season with Delegate Source[1] The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System[0] ATR: Baucus Earns Place on 2009 "Naughty" List[0] Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis [2] TrekDesk: A Potentially Positive Impact on Diabetes & Obesity
VorinostatGVAXGenesysInjectHomosexualsRapesResponsiveDoxilCalamitiesBalloonsDalDesperateNonsmallJury
Other Tagsbear 2bear 3bear 4bear 5bear 6colleagues 2colleagues 3colleagues 4colleagues 5colleagues 6colleagues 7colleagues 8colleagues 9colleagues 10connecting 2cultured 2cultured 3cultured 4cultured 5cultured 6cultured 7| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |